Zacks: Brokerages Expect Aquabounty Technologies Inc (AQB) Will Announce Quarterly Sales of $120,000.00
Wall Street analysts expect that Aquabounty Technologies Inc (NASDAQ:AQB) will post $120,000.00 in sales for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Aquabounty Technologies’ earnings. The highest sales estimate is $220,000.00 and the lowest is $20,000.00. The business is expected to report its next quarterly earnings results on Thursday, March 14th.
On average, analysts expect that Aquabounty Technologies will report full year sales of $200,000.00 for the current year, with estimates ranging from $100,000.00 to $300,000.00. For the next financial year, analysts anticipate that the firm will post sales of $1.11 million, with estimates ranging from $600,000.00 to $1.62 million. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow Aquabounty Technologies.
Aquabounty Technologies (NASDAQ:AQB) last released its earnings results on Friday, November 2nd. The company reported ($0.21) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.01). The company had revenue of $0.01 million during the quarter, compared to analysts’ expectations of $0.14 million.
An institutional investor recently raised its position in Aquabounty Technologies stock. ARK Investment Management LLC increased its stake in Aquabounty Technologies Inc (NASDAQ:AQB) by 81.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 170,697 shares of the company’s stock after purchasing an additional 76,458 shares during the quarter. ARK Investment Management LLC owned approximately 1.33% of Aquabounty Technologies worth $568,000 as of its most recent filing with the Securities and Exchange Commission. 54.25% of the stock is currently owned by hedge funds and other institutional investors.
NASDAQ:AQB opened at $2.52 on Thursday. The stock has a market cap of $37.60 million, a P/E ratio of -2.38 and a beta of -0.66. Aquabounty Technologies has a 52-week low of $2.25 and a 52-week high of $9.99. The company has a current ratio of 0.98, a quick ratio of 0.94 and a debt-to-equity ratio of 0.14.
About Aquabounty Technologies
AquaBounty Technologies, Inc, a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc and changed its name to AquaBounty Technologies, Inc in June 2004.
See Also: Float
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aquabounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aquabounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.